SCHEMBL12882199

SCHEMBL12882199

COc1ccc(C(=O)n2cc(F)c(N)nc2=O)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ USP2 O75604 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ KLK7 P49862 1/20 0.46
▸ MAPK10 P53779 1/20 0.46
▸ KLK5 Q9Y337 1/20 0.46
▸ MAPT P10636 4/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ POLB P06746 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ F12 P00748 3/20 0.43
▸ F2 P00734 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12882191 0.84 KMT2A (0.51) KMT2ANPC1RAB9AKDM4EKLK7
SCHEMBL12882215 0.82 CES2 (0.42) KMT2A
SCHEMBL4320783 0.79 KMT2A (0.49) HSD17B10KMT2ANPC1RAB9AKDM4E
SCHEMBL1224575 0.76 CES2 (0.36) KMT2AMAPTTSHR
SCHEMBL12883793 0.73 EP300 (0.38) KMT2AMAPK1
SCHEMBL12883780 0.71 DCK (0.42) KMT2ANPC1RAB9AKDM4EMAPK1
SCHEMBL1739594 0.71 ALB (0.38) —
SCHEMBL12882192 0.70 KMT2A (0.47) KMT2AKDM4EMAPTPOLBTHRB
SCHEMBL6880479 0.69 KMT2A (0.52) KMT2ANPC1RAB9AKDM4EMAPK1
SCHEMBL1224879 0.68 EP300 (0.46) HSD17B10KMT2AKDM4EPOLBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519512-B1 N1-ACYL- 5-FLUOROPYRIMIDINONE DERIVATIVES ADAMA MAKHTESHIM LTD (IL) 2019-03-20 — — EP disclosed
US-8470839-B2 N1-acyl-5-fluoropyrimidinone derivatives DOW AGROSCIENCES, LLC. (US) 2013-06-25 — — US disclosed
US-8470839-B2 N1-acyl-5-fluoropyrimidinone derivatives DOW AGROSCIENCES, LLC. (US) 2013-06-25 — — US disclosed
US-20110034490-A1 N1-acyl-5-fluoropyrimidinone derivatives DOW AGROSCIENCES LLC (US) 2011-02-10 — — US disclosed
WO-2011017538-A1 N1-ACYL-5-FLUOROPYRIMIDINONE DERIVATIVES DOW AGROSCIENCES LLC (US) 2011-02-10 — — WO disclosed
US-20110034490-A1 N1-acyl-5-fluoropyrimidinone derivatives DOW AGROSCIENCES LLC (US) 2011-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110034490-A1 N1-acyl-5-fluoropyrimidinone derivatives NANP, NAT1, AKR7A2 HSD17B10 1706/4885KMT2A 1286/4885NPC1 963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback